Parantaa Drugs Private Limited, a active private limited company, was established on 06 February 2021 in Guwahati, Assam, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U85110AS2021PTC020971. Registered under ROC Roc Guwahati. it is unlisted. It has an authorized capital of ₹1.50 M and a paid-up capital of ₹1.50 M.
Employing 7 professional, Its leadership includes Purnima Bora (Director), Rinji Borah (Director), Jyotishmoy Bora (Director). Past directors included Purnima Bora, Rinji Borah, Taruni Hazarika. It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at W/O Surendra Nath Bora , H/No-49, Rupnagar Near L.P School,, Guwahati, Assam, 781032.
U85110AS2021PTC020971
020971
06 February 2021
₹1.50 M
₹1.50 M
Roc Guwahati
Unlisted
Active
Explore comprehensive insights into Parantaa Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Purnima Bora | Director | 28 Jun 2021 | Current |
| Rinji Borah | Director | 28 Jun 2021 | Current |
| Jyotishmoy Bora | Director | 06 Feb 2021 | Current |
| Sahadev Dam | Director | 06 May 2024 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2022 | Past |
| Pramod Abcsdd | Director | 15 Jul 2024 | Past |
| Pramod Abcsdd | Director | 08 Sep 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Parantaa Drugs Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1096902.39% increase. The company also saw a substantial improvement in profitability, with a 130488.99% increase in profit. The company's net worth Soared by an impressive increase of 109361.09%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Parantaa Drugs's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Dec 2023 | Others | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Parantaa Drugs has a workforce of 7 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Parantaa Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parantaa Drugs's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Parantaa Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
The activity Parantaa Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Guwahati. was completed.
A charge with Others of Rs. 5.00 M registered on 26 Dec 2023 with Charge ID 100836602 was modified on 27 Feb 2025. was recorded as a recent event.
Sahadev Dam was appointed as a Director was appointed as a Director on 06 May 2024 & has been associated with this company since 1 year 7 months . was recorded as a recent event.
Progress on A charge with Others amounted to Rs. 5.00 M with Charge ID 100836602 was registered on 26 Dec 2023. was documented.
The activity Purnima Bora was appointed as a Director was appointed as a Director on 28 Jun 2021 & has been associated with this company since 4 years 5 months . was completed.
The CIN of Parantaa Drugs Private Limited is U85110AS2021PTC020971.
Parantaa Drugs Private Limited is headquartered at W/O Surendra Nath Bora , H/No-49, Rupnagar Near L.P School,, Guwahati, Assam, 781032.
Parantaa Drugs Private Limited was incorporated on 06 February 2021.
The current directors of Parantaa Drugs Private Limited are
The primary industry of Parantaa Drugs Private Limited is Trade.
Parantaa Drugs Private Limited is unlisted.
The authorized capital of Parantaa Drugs Private Limited is ₹1.50 M, and the paid-up capital is ₹1.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX